학술논문
Immunogenicity and safety assessment of a SARS-CoV-2 recombinant spike RBD protein vaccine (Abdala) in paediatric ages 3-18 years old: a double-blinded, multicentre, randomised, phase 1/2 clinical trial (ISMAELILLO study)
Document Type
Journal
Author
Cinza-Estevez, Zurina; Resik-Aguirre, Sonia; Figueroa-Baile, Nelvis L.; Oquendo-Martinez, Rachel; Campa-Legra, Ivan; Tejeda-Fuentes, Alina; Rivero-Caballero, Marila; Gonzalez-Garcia, Gloria; Chavez-Chong, Cristina O.; Alonso-Valdes, Marel; Hernandez-Bernal, Francisco; Lemos-Perez, Gilda; Campal-Espinosa, Ana; Freyre-Corrales, Giselle; Benitez-Gordillo, Delia; Gato-Orozco, Evelyn; Bartutis, Greter Susana Perez; Mesa-Pedroso, Iliana; Bueno-Alemani, Nilda; Infante-Aguilar, Elizabeth; Reinoso, Jose Luis Rodriguez; Melo-Suarez, Grettel; Limonta-Fernandez, Miladys; Ayala-Avila, Marta; Muzio-Gonzalez, Verena L.; ISMAELILLO Clin Trial Grp
Source
Subject
Language
English
ISSN
25895370